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Abstract
The SOX2 anophthalmia syndrome is emerging as a clinically recognizable disorder that has been
identified in 10–15% of individuals with bilateral anophthalmia. Extra-ocular anomalies are
common. The majority of SOX2 mutations identified appear to arise de novo in probands
ascertained through the presence of anophthalmia or microphthalmia. In this report, we describe
two sisters with bilateral anophthalmia/microphthalmia, brain anomalies and a novel heterozygous
SOX2 gene single-base pair nucleotide deletion, c.551delC, which predicts p.Pro184ArgfsX19.
The hypothetical protein product is predicted to lead to haploinsufficient SOX2 function.
Mosaicism for this mutation in the SOX2 gene was also identified in their clinically unaffected
mother in peripheral blood DNA. Thus it cannot be assumed that all SOX2 mutations in
individuals with anophthalmia /microphthalmia are de novo. Testing of parents is indicated when
a SOX2 mutation is identified in a proband.
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INTRODUCTION
The SOX2 anophthalmia syndrome is emerging as a recognizable pleiotropic phenotype. In
screening groups of individuals with anophthalmia or microphthalmia, SOX2 mutations
account for 10–15%. [Ragge et al., 2005; Faivre et al., 2006; Williamson et al., 2006]. Extra-
ocular anomalies are common. The phenotype includes bilateral anophthalmia or severe
microphthalmia, variable developmental delay with specific motor abnormalities, seizures,
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brain anomalies, male genital anomalies, mild dysmorphic facial features and short stature
[Ragge et al., 2005].
To date most individuals described with SOX2 anophthalmia syndrome have had de novo
mutations in SOX2 with bilateral anophthalmia or microphthalmia as the presenting feature.
SOX2 mutations have also been identified in a group of individuals with
anophthalmiaesophageal-genital (AEG) syndrome (OMIM 600992), an association of
anophthalmia or microphthalmia, esophageal atresia with or without tracheo-esophageal
fistula, and urogenital anomalies, most commonly cryptorchidism, hypospadias and
micropenis [Williamson et al., 2006]. Recently Zenteno et al. [2006] described discordant
monozygotic twin males who have c.70del20 mutation in SOX2. One twin had unilateral
anophthalmia and esophageal atresia and the other twin had normal size corneas but a short
palpebral fissure of one eye and esophageal atresia. All other studies were unremarkable.
Chassaing et al. [2007] proposed germinal mosaicism in the mother of two affected female
pregnancies with markedly different phenotypes. The first child had AEG syndrome with
type III esophageal atresia. Prenatal ultrasound in the second pregnancy noted progressive
hydrocephalus. Autopsy of the female fetus showed brain anomalies and 11 pairs of ribs but
normal eyes including normal ocular microscopy. Both offspring had a c.70_86del mutation,
which was not found in either parent on sequencing.
We describe two sisters with bilateral anophthalmia, brain anomalies and a novel
heterozygous c.551delC SOX2mutation, which predicts p.Pro184ArgfsX19.
CLINICAL REPORT
The proband (Fig 1) was born at term to a G3P2 32-year-old healthy mother. Parents are not
consanguineous and have two unaffected older children. This 7-year-old girl had right
anophthalmia and left marked microphthalmia with light perception in the left eye only.
Prenatal ultrasound showed a right arachnoid cyst and mild hydrocephalus. The patient's
Apgar scores were 8 and 9. Her birth weight was 3685 g (~ 50th centile) and birth length was
reportedly normal. A cranial MRI at age 3 years showed hypoplastic globes, right middle
fossa arachnoid cyst, mild hydrocephalus, and partial absence of the posterior aspect of the
corpus callosum including the splenium. Electroencephalogram confirmed partial complex
seizures at 3 years of age. A sleep study confirmed disordered breathing with obstructive
and central hypopnea.
Feeding and swallowing difficulties were present up to age 5 years. Growth hormone
deficiency was diagnosed at age 20 months. Her IGF Binding Protein was 0.8 mg/L. She
responded to human growth hormone therapy. At 19 months she had a TSH level of 3.9 uIU/
mL; normal range (0.4–2.5 uIU/mL) and thyroid hormone supplements were initiated.
The patient had speech delays with receptive language better than expressive. She used
limited sign language but was essentially non-verbal. She recognized family members and
showed affection. She had motor delays and walked at age 4 years with assistance. She had
a wide-based ataxic gait and locked her knees for balance. She needed her hand held or a
walker for stability outside the house. Her mother reported that her daughter continued to
make developmental progress in all areas except speech. She was not toilet trained.
On examination at age 7 years she weighed 19 kg (~25th centile); her height was 109.2 cm
(<3rd centile) and her OFC was 48.2 cm (3rd to 5th centile). Bilateral clinical anophthalmia
with deep set eyes and facial asymmetry were noted. She had a prominent down curved
nasal tip, small, widely spaced teeth, diastasis recti, and hypoplastic labia minora. She had
tactile defensiveness.
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The second affected child in this family was identified prenatally. An ultrasound at 23 weeks
gestation revealed underdevelopment of the globes (Fig 2). Anophthalmia was suspected
based on the family history of an affected sibling. An amniocentesis was performed and
chromosome study and the karyotype was 46,XX. Her birth weight was 4054 g and length
was 52 cm (both appropriate for gestational age). Newborn hearing screen was normal. On
ultrasound of the orbit shortly after birth, no globe was noted bilaterally. She had no
response to light.
When re-examined at 4 months her height was 61.2cm (~50th centile), her weight was 5.3kg
(~25th centile) and OFC was 37.8cm ( <3rd centile). No dysmorphic features were described
except for absent ocular structures and short palpebral fissures. (Fig 1). A cranial MRI at age
4 months showed partial agenesis of the corpus callosum and hypoplasia of the orbits and
maxillae with visualization of the extraocular muscles and lacrimal glands. Minimal ocular
tissue was noted in the orbit. The optic nerves were not visualized.
At about 9 months she had a TSH level of 10.5 uIU/mL; normal range (0.4–2.4 uIU/mL) and
was treated with thyroid supplements. She was growing along a low centile but growth
hormone levels were normal.
At age 14 months she developed blotchy red areas of skin on her back and abdomen. These
regressed but have been replaced with hyperpigmented areas and were diagnosed as urticaria
pigmentosa.
Her development was delayed. At age 16 months she sat without support, rolled, babbled
with consonants and vowels. She finger fed herself and had no feeding difficulty. Her
development was more advanced than that of her sister, the proband, at the equivalent age.
Head circumference at 25 months was 43.3 cm (< 3rd centile). She was interactive, babbling
and using occasional words like “Mama” and Dada”. She could feed herself and transfer
toys from hand to hand. Muscle tone was generally decreased but she was able to bear
weight although she could not walk.
Unaffected mother
The mother (Fig 1) had normal vision and an unremarkable ophthalmology examination.
She had normal motor abilities and apparently normal intellect. Cranial MRI was normal.
METHODS
Clinical data were collected by the Anophthalmia/Microphthalmia Registry at the Albert
Einstein Medical Center by review of medical records and clinical evaluation of the proband
by one of the authors (AS). Institutional Review Board (IRB) approval has been obtained
from the AEMC IRB. This study was also approved by the IRB of the Children's Hospital of
Philadelphia. Peripheral blood samples (10–20 ml) and buccal swabs were collected and
genomic DNA was extracted using the Puregene DNA isolation kit (Gentra Systems,
Minneapolis, MN). Cord blood was collected from the affected sibling at birth for DNA
extraction and testing. Standard PCR was performed on genomic DNA of affected patients,
unaffected relatives, and healthy controls (matched for race and ethnicity) to amplify the 11
primer pair sets designed to cover SOX2 exonic regions. An additional 120 base pairs of
intronic sequence at both the 5'- and 3'- ends were also analyzed. Patient DNA samples were
first amplified and screened for possible mutations using conformation sensitive gel
electrophoresis [Ganguly, 2002, Korkko et al., 1998].
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Samples with abnormal migration patterns were selected for direct sequencing. These
samples were purified by ExoSap-IT (USB Corp., Cleveland, OH) per manufacturer's
protocol. Direct sequencing was performed on the 3730 DNA Analyzer (Applied
Biosystems, Inc.) using the Big Dye Termination v3.1 Cycle sequencing kit (Applied
Biosytems, Inc., Foster City, CA). All migration pattern changes underwent a second
screening using bi-directional sequencing of patient DNA samples, with comparative normal
controls.
To establish maternal mosaicism PCR sequencing was performed with the 3' SOX2 primers
(5'GGCGTGAACCAGCGCATGG and 5′GGAGCGTACCGGGTTTTCTC) as previously
described [Williamson et al., 2006] on amplicons generated from genomic DNA from the
mother and both affected children.
RESULTS
A novel heterozygous SOX2 c.551delC mutation was noted in the proband and her sibling.
The identical mutation was identified in the unaffected mother on sequencing of the
peripheral blood with an apparently lower level of mutant allele than the probands. Maternal
grandparents were tested at GeneDx laboratories (Gaithersburg, MD) for this familial SOX2
mutation and neither carried the mutation.
This mutation predicts p.Pro184ArgfsX19. We hypothesize that the predicted shortened
protein product results in loss of SOX2 function.
DISCUSSION
Anophthalmia and microphthalmia (A/M) are considered to be the severe end of a spectrum
of ocular anomalies, which include coloboma. These malformations are etiologically
heterogeneous. Recent studies have demonstrated that heterozygous loss of function
mutations in SOX2 in10–15% of patients with bilateral anophthalmia [Faivre et al., 2006;
Williamson et al., 2006]. Most of the mutations are de novo in the probands.
We report the third family with an unaffected mother who has two offspring with bilateral
A/M and a mutation in SOX2 [Faivre et al., 2006; Chassaing et al., 2007]. All the families
described to date have two female children. Of interest is that the mutation in the mother in
the family described by Faivre et al. [2006] was identified with lower intensity in peripheral
blood and buccal studies compared to the probands and, like the present case, was
considered to be a consequence of somatic mosaicism.
Chassaing et al. [2007] proposed germinal mosaicism in the mother of two affected female
pregnancies with markedly different phenotypes. In the second pregnancy, terminated at 20
weeks, the fetus had normal eyes and significant brain anomalies with a non-mosaic SOX2
deletion mutation, which had been identified in the sibling with bilateral anophthalmia. The
deletion was not identified in the peripheral blood or buccal cells of the mother on
sequencing. Semiquantitative capillary electrophoresis of fluorescent SOX2 PCR fragments,
encompassing the deleted region, detected mosaicism of approximately 3% for the SOX2
deletion identified in her children.
The frame-shift mutation described in this report is predicted to cause a premature
termination of the coding sequence. Two tissues were studied in all individuals; peripheral
blood DNA was initially studied and the confirmation used buccal cell DNA. There was
evidence of reduced signal in the unaffected mother thus confirming somatic mosaicism.
However, the level of mosaicism can not be accurately quantified (Fig 3).
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Common to these three families, are maternal transmission and affected female children.
Ragge et al. [2005] noted that there was an excess of females in her cohort and that males
appear to be more severely affected. Some males with SOX2 anophthalmia syndrome have
genital tract anomalies [Ragge et al., 2005; Williamson et al., 2006]. Interestingly, the
heterozygous Sox2 knockout mouse shows reduced male fertility as its only anomaly
[Avilion et al., 2003]. This may reflect a sex influenced effect of SOX2 mutation. There is
also no indication of imprinting in this area of chromosome 3q to explain the preponderance
of females affected with SOX2 anophthalmia. [Xiao et al., 2006].
A recent report identified monozygotic twin brothers with a SOX2 20 base pair deletion and
markedly discordant ocular phenotypes [Zenteno et al., 2006]. Twin A had unilateral
anophthalmia and esophageal atresia. Twin B had esophageal atresia with normal
ophthalmologic evaluation apart from a narrow palpebral fissure on the right. These cases
and the family we report here provide evidence that significant levels of mosaicism for a
SOX2 loss-of function mutation can be found in individuals with normal ocular phenotype
confirming previous work that shows not all cases are the result of a new mutation. The
phenotype of SOX2 anophthalmia syndrome is variable even with the same mutation, as
underscored by the twins described above and the description of Chassaing et al. [2007].
Developmental delay is common with delayed motor milestones and an unsteady ataxic gait.
The family described here demonstrates that differences in development may occur in
siblings with the same SOX2 mutation. Hypothyroidism has not been described previously
in SOX2 anophthalmia syndrome. Given, the finding of hypothyroidism in these children,
clinicians who evaluate patients with SOX2 anophthalmia syndrome should consider
screening for hypothyroidism if clinically indicated. The urticaria pigmentosa in the sibling
of the proband may be unrelated to the SOX2 mutation. Some cases of urticaria pigmentosa
have been identified in families as autosomal dominant with incomplete penetrance.
However most cases of pediatric mastocytosis in children, of which urticaria pigmentosa is
the most frequent variant, are sporadic. [Rosbotham et al., 1999; Ben-Amitai et al., 2005] As
more cases of SOX2 anophthalmia syndrome are identified the phenotype will likely
expand.
In conclusion, the finding of an unaffected parent with a mosaic SOX2 mutation raises
issues about the evaluation of the parents of all individuals with anophthalmia. We
recommend SOX2 mutation testing for any patient with anophthalmia or microphthalmia. A
positive result should include testing the parents for the specific SOX2 mutation. However,
the level of mosaicism varies and may be missed on sequencing as in the case of Chassaing
et al [2007]. Recurrence risk assessments in these families should take into account potential
germinal mosaicism with low levels of somatic mosaicism. Prenatal testing in future
pregnancies should be made available following the birth of a child with a SOX2 mutation.
This will enable the genetics community to provide accurate recurrence risks to these
individuals and families. It will also enable prenatal or preimplantation testing for SOX2
mutations in those families with a parent suspected or proven to be mosaic.
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Figure 1.
Phenotypically unaffected mother with proband on the left and sibling on her lap. The
features in the proband include bilateral anophthalmia, downturned nasal tip and small,
widely spaced teeth
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Figure 2.
Prenatal sonogram of fetus at 23 weeks gestation
A. Frontal view of left orbit shows B. Axial view through both orbits. Inner and outer orbital
measurements below 5th centile for gestational age. Outer orbital distance 2.69cm Inner
orbital distance 0.94cm Axial orbital measurement estimated 8 mm (below -2 SD for
gestational age)
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Figure 3.
Confirmation of maternal mosaicism: The c.551delC (g.982delC NC_000003 REGION:
182912416..182914918) mutation creates frameshift in the forward strand of the sequencing
trace. The individual peak heights were used to calculate a wild-type to mutant ratio for the
mother and both affected children. The uncorrected ratios were 3.2, 1.4 and 1.5 respectively.
Normalizing the ratio by assuming the affected children are obligate heterozygotes gives a
corrected ratio for the mother of 2.3 and strongly suggests that the mother is mosaic.
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